UZE Form 144: Insider Notice to Sell 1,960 Shares ($148K)
Form 144 notice for United States Cellular Corporation (UZE).
Rhea-AI Filing Summary
Form 144 notice for United States Cellular Corporation (UZE). The filer reports a proposed sale of 1,960 common shares, acquired as vested RSAs on 08/01/2025 with payment characterized as equity compensation. The aggregate market value of the shares at reporting is $148,372.00, against 53,000,000 shares outstanding. The seller lists an approximate sale date of 08/18/2025 and the sale is to be executed through Charles Schwab Corp. on the NYSE. The filing states there were no securities sold by the seller in the past three months and includes the seller's certification about lack of undisclosed material information.
Positive
- Clear disclosure of number of shares to be sold (1,960) and aggregate market value ($148,372.00)
- Transaction source disclosed as vested RSAs with equity compensation payment characterization
- Broker and market specified: Charles Schwab Corp. on the NYSE, with an approximate sale date of 08/18/2025
- Seller attestation that there is no undisclosed material adverse information and statement that no securities were sold in the past three months
Negative
- Filer contact and issuer identification fields appear incomplete or blank in the provided content
- Filing contains minimal context about the seller's identity or any trading plan details beyond the basic attestation
Insights
TL;DR: A small equity-compensation share sale is planned and appears routine, with limited direct impact on company capital structure.
The notice documents a proposed disposition of 1,960 common shares obtained as vested restricted stock awards on 08/01/2025. The transaction is scheduled through Charles Schwab on the NYSE on or about 08/18/2025, with an aggregate reported market value of $148,372.00. The filing reports no sales by the holder in the last three months and includes the standard attestation of no undisclosed material information. From a capital-markets perspective, this appears to be an individual insider's routine sale of vested equity rather than a corporate financing event.
TL;DR: Document is a standard compliance filing for insider sales tied to equity compensation, emphasizing required attestations.
The Form 144 discloses that the securities to be sold were acquired as vested RSAs and that the seller certifies absence of undisclosed material information. The form lists the broker and an approximate sale date, and explicitly notes no securities sold in the prior three months by the same person. The filing fulfills Rule 144 notification requirements and includes the statutory warning about intentional misstatements. No governance red flags or material compliance exceptions are apparent from the notice itself.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filed for UZE disclose?
Does the filing report any securities sold by the same person in the past three months?
When is the proposed sale date listed in the Form 144?
Which broker is named to execute the proposed sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.